{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Bergenin", "Cervical cancer", "Galectin 3", "HPV", "Matrix metallo protease 9"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38961106", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "03"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "09"}, "Article": {"Language": ["eng"], "ELocationID": ["15287", "10.1038/s41598-024-64781-3"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "03"}], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "14", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "03"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression.", "Pagination": {"StartPage": "15287", "MedlinePgn": "15287"}, "Abstract": {"AbstractText": ["Cervical cancer is still the leading cause of cancer mortality worldwide even after introduction of vaccine against Human papillomavirus (HPV), due to low vaccine coverage, especially in the developing world. Cervical cancer is primarily treated by Chemo/Radiotherapy, depending on the disease stage, with Carboplatin/Cisplatin-based drug regime. These drugs being non-specific, target rapidly dividing cells, including normal cells, so safer options are needed for lower off-target toxicity. Natural products offer an attractive option compared to synthetic drugs due to their well-established safety profile and capacity to target multiple oncogenic hallmarks of cancer like inflammation, angiogenesis, etc. In the current study, we investigated the effect of Bergenin (C-glycoside of 4-O-methylgallic acid), a natural polyphenol compound that is isolated from medicinal plants such as Bergenia crassifolia, Caesalpinia digyna, and Flueggea leucopyrus. Bergenin has been shown to have anti-inflammatory, anti-ulcerogenic, and wound healing properties but its anticancer potential has been realized only recently. We performed a proteomic analysis of cervical carcinoma cells treated with bergenin and found it to influence multiple hallmarks of cancers, including apoptosis, angiogenesis, and tumor suppressor proteins. It was also involved in many different cellular processes unrelated to cancer, as shown by our proteomic analysis. Further analysis showed bergenin to be a potent-angiogenic agent by reducing key angiogenic proteins like Galectin 3 and MMP-9 (Matrix Metalloprotease 9) in cervical carcinoma cells. Further understanding of this interaction was carried out using molecular docking analysis, which indicated MMP-9 has more affinity for bergenin as compared to Galectin-3. Cumulatively, our data provide novel insight into the anti-angiogenic mechanism of bergenin in cervical carcinoma cells by modulation of multiple angiogenic proteins like Galectin-3 and MMP-9 which warrant its further development as an anticancer agent in cervical cancer."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology (Lab.), Dr. BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India."}], "LastName": "Chauhan", "ForeName": "Ravi", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, Sri Venkateswara College, University of Delhi, New Delhi, India."}], "LastName": "Malhotra", "ForeName": "Lakshay", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology (Lab.), Dr. BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India."}], "LastName": "Gupta", "ForeName": "Ashna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology (Lab.), Dr. BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India."}], "LastName": "Dagar", "ForeName": "Gunjan", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, Dr. BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India."}], "LastName": "Mendiratta", "ForeName": "Mohini", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Cancer Immunology and Genetics, Sidra Medicine, Doha, Qatar."}], "LastName": "Masoodi", "ForeName": "Tariq", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Genetics, Sidra Medicine, Doha, Qatar."}], "LastName": "Hashem", "ForeName": "Sheema", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Genetics-Precision Medicine in Diabetes, Obesity and Cancer Program, Sidra Medicine, Doha, Qatar."}], "LastName": "Al Marzooqi", "ForeName": "Sara", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, NYU Langone Health, New York, 10016, USA."}], "LastName": "Das", "ForeName": "Dayasagar", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar."}], "LastName": "Uddin", "ForeName": "Shahab", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India."}], "LastName": "Ethayathulla", "ForeName": "Abdul Samath", "Initials": "AS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Pulwama, Jammu and Kashmir, India."}], "LastName": "Macha", "ForeName": "Muzafar A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Genetics-Precision Medicine in Diabetes, Obesity and Cancer Program, Sidra Medicine, Doha, Qatar."}], "LastName": "Akil", "ForeName": "Ammira Al-Shabeeb", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology, Dr. BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India."}], "LastName": "Sahoo", "ForeName": "Ranjit Kumar", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences Jawahar Lal Nehru University, New Delhi, India."}], "LastName": "Rai", "ForeName": "Ekta", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Genetics-Precision Medicine in Diabetes, Obesity and Cancer Program, Sidra Medicine, Doha, Qatar."}], "LastName": "Bhat", "ForeName": "Ajaz A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Oncology (Lab.), Dr. BRAIRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India. mayank.osu@gmail.com."}], "LastName": "Singh", "ForeName": "Mayank", "Initials": "M"}], "GrantList": [{"GrantID": "AI 34", "Agency": "All-India Institute of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "L84RBE4IDC", "NameOfSubstance": "bergenin"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "Matrix Metalloproteinase 9"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzopyrans"}, {"RegistryNumber": "0", "NameOfSubstance": "Galectin 3"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "MMP9 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "LGALS3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Galectins"}, {"RegistryNumber": "0", "NameOfSubstance": "Blood Proteins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Matrix Metalloproteinase 9"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Benzopyrans"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Uterine Cervical Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Galectin 3"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Galectins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "HeLa Cells"}, {"QualifierName": [], "DescriptorName": "Blood Proteins"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin. J. Cancer Res. 2020;32(6):720. doi: 10.21147/j.issn.1000-9604.2020.06.05.", "ArticleIdList": ["10.21147/j.issn.1000-9604.2020.06.05", "PMC7797226", "33446995"]}, {"Citation": "Nour NM. Cervical cancer: A preventable death. Rev. Obstet. Gynecol. 2009;2(4):240.", "ArticleIdList": ["PMC2812875", "20111660"]}, {"Citation": "Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. Human papillomavirus infection and cervical cancer: Epidemiology, screening, and vaccination\u2014Review of current perspectives. J. Oncol. 2019;2019:1\u201311. doi: 10.1155/2019/3257939.", "ArticleIdList": ["10.1155/2019/3257939", "PMC6811952", "31687023"]}, {"Citation": "Burmeister CA, Khan SF, Sch\u00e4fer G, Mbatani N, Adams T, Moodley J, et al. Cervical cancer therapies: Current challenges and future perspectives. Tumour Virus Res. 2022;13:200238. doi: 10.1016/j.tvr.2022.200238.", "ArticleIdList": ["10.1016/j.tvr.2022.200238", "PMC9062473", "35460940"]}, {"Citation": "Otrock ZK, Mahfouz RA, Makarem JA, Shamseddine AI. Understanding the biology of angiogenesis: Review of the most important molecular mechanisms. Blood Cells Mol. Dis. 2007;39(2):212\u2013220. doi: 10.1016/j.bcmd.2007.04.001.", "ArticleIdList": ["10.1016/j.bcmd.2007.04.001", "17553709"]}, {"Citation": "Sharma A, Singh M, Chauhan R, Malik PS, Khurana S, Mathur S, et al. Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial. Gynecol. Oncol. 2021;162(2):382\u2013388. doi: 10.1016/j.ygyno.2021.05.025.", "ArticleIdList": ["10.1016/j.ygyno.2021.05.025", "34088513"]}, {"Citation": "Nguyen NH, Ta QTH, Pham QT, Luong TNH, Phung VT, Duong TH, et al. Anticancer activity of novel plant extracts and compounds from Adenosma bracteosum (Bonati) in human lung and liver cancer cells. Molecules. 2020;25(12):2912. doi: 10.3390/molecules25122912.", "ArticleIdList": ["10.3390/molecules25122912", "PMC7356985", "32599892"]}, {"Citation": "Nisar S, Masoodi T, Prabhu KS, Kuttikrishnan S, Zarif L, Khatoon S, et al. Natural products as chemo-radiation therapy sensitizers in cancers. Biomed. Pharmacother. 2022;154:113610. doi: 10.1016/j.biopha.2022.113610.", "ArticleIdList": ["10.1016/j.biopha.2022.113610", "36030591"]}, {"Citation": "Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, et al. Targeting cancer signaling pathways by natural products: Exploring promising anticancer agents. Biomed. Pharmacother. 2022;150:113054. doi: 10.1016/j.biopha.2022.113054.", "ArticleIdList": ["10.1016/j.biopha.2022.113054", "35658225"]}, {"Citation": "Singh M, Singh N. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol. Cell. Biochem. 2009;325(1):107\u2013119. doi: 10.1007/s11010-009-0025-5.", "ArticleIdList": ["10.1007/s11010-009-0025-5", "19191010"]}, {"Citation": "Singh M, Singh N. Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Mol. Cell. Biochem. 2011;347(1):1\u201311. doi: 10.1007/s11010-010-0606-3.", "ArticleIdList": ["10.1007/s11010-010-0606-3", "20941532"]}, {"Citation": "Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol. Cancer. 2011;10(1):1\u201314. doi: 10.1186/1476-4598-10-39.", "ArticleIdList": ["10.1186/1476-4598-10-39", "PMC3098825", "21496227"]}, {"Citation": "Bajracharya GB. Diversity, pharmacology and synthesis of bergenin and its derivatives: Potential materials for therapeutic usages. Fitoterapia. 2015;101:133\u2013152. doi: 10.1016/j.fitote.2015.01.001.", "ArticleIdList": ["10.1016/j.fitote.2015.01.001", "25596093"]}, {"Citation": "Liu J, Zhang Y, Yu C, Zhang P, Gu S, Wang G, et al. Bergenin inhibits bladder cancer progression via activating the PPAR\u03b3/PTEN/Akt signal pathway. Drug Dev. Res. 2021;82(2):278\u2013286. doi: 10.1002/ddr.21751.", "ArticleIdList": ["10.1002/ddr.21751", "33112006"]}, {"Citation": "Sultana T, Mitra AK, Das S. Evaluation of anticancer potential of Excoecaria agallocha (L.) leaf extract on human cervical cancer (SiHa) cell line and assessing the underlying mechanism of action. Future J. Pharm. Sci. 2022;8(1):1\u201318."}, {"Citation": "Jayakody RS, Wijewardhane P, Herath C, Perera S. Bergenin: A computationally proven promising scaffold for novel galectin-3 inhibitors. J. Mol. Model. 2018;24(10):1\u201311. doi: 10.1007/s00894-018-3831-4.", "ArticleIdList": ["10.1007/s00894-018-3831-4", "30276553"]}, {"Citation": "Chen CY, Chen J, He L, Stiles BL. PTEN: Tumor suppressor and metabolic regulator. Front. Endocrinol. 2018;9:338. doi: 10.3389/fendo.2018.00338.", "ArticleIdList": ["10.3389/fendo.2018.00338", "PMC6046409", "30038596"]}, {"Citation": "Kreis NN, Louwen F, Yuan J. The multifaceted p21 (Cip1/Waf1/CDKN1A) in cell differentiation, migration and cancer therapy. Cancers. 2019;11(9):1220. doi: 10.3390/cancers11091220.", "ArticleIdList": ["10.3390/cancers11091220", "PMC6770903", "31438587"]}, {"Citation": "Zhao M, Mishra L, Deng CX. The role of TGF-\u03b2/SMAD4 signaling in cancer. Int. J. Biol. Sci. 2018;14(2):111. doi: 10.7150/ijbs.23230.", "ArticleIdList": ["10.7150/ijbs.23230", "PMC5821033", "29483830"]}, {"Citation": "Li X, Wang F, Xu X, Zhang J, Xu G. The dual role of STAT1 in ovarian cancer: Insight into molecular mechanisms and application potentials. Front. Cell Dev. Biol. 2021;9:636595. doi: 10.3389/fcell.2021.636595.", "ArticleIdList": ["10.3389/fcell.2021.636595", "PMC8021797", "33834023"]}, {"Citation": "Ribatti D, Tamma R, Annese T. Epithelial\u2013mesenchymal transition in cancer: A historical overview. Transl. Oncol. 2020;13(6):100773. doi: 10.1016/j.tranon.2020.100773.", "ArticleIdList": ["10.1016/j.tranon.2020.100773", "PMC7182759", "32334405"]}, {"Citation": "Tochowicz A, Maskos K, Huber R, Oltenfreiter R, Dive V, Yiotakis A, et al. Crystal structures of MMP-9 complexes with five inhibitors: Contribution of the flexible Arg424 side-chain to selectivity. J. Mol. Biol. 2007;371(4):989\u20131006. doi: 10.1016/j.jmb.2007.05.068.", "ArticleIdList": ["10.1016/j.jmb.2007.05.068", "17599356"]}, {"Citation": "Rowsell S, Hawtin P, Minshull CA, Jepson H, Brockbank SM, Barratt DG, et al. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. J. Mol. Biol. 2002;319(1):173\u2013181. doi: 10.1016/S0022-2836(02)00262-0.", "ArticleIdList": ["10.1016/S0022-2836(02)00262-0", "12051944"]}, {"Citation": "Claudia, A., et al. Crystallization of bi-functional ligand protein complexes. (2013).", "ArticleIdList": ["23567804"]}, {"Citation": "Tranchant I, Vera L, Czarny B, Amoura M, Cassar E, Beau F, et al. Halogen bonding controls selectivity of FRET substrate probes for MMP-9. Chem. Biol. 2014;21(3):408\u2013413. doi: 10.1016/j.chembiol.2014.01.008.", "ArticleIdList": ["10.1016/j.chembiol.2014.01.008", "24583051"]}, {"Citation": "Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907. doi: 10.1016/S0140-6736(07)61416-0.", "ArticleIdList": ["10.1016/S0140-6736(07)61416-0", "17826171"]}, {"Citation": "Yang J, Cai H, Xiao ZX, Wang H, Yang P. Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database. Medicine. 2019;98(30):e16421. doi: 10.1097/MD.0000000000016421.", "ArticleIdList": ["10.1097/MD.0000000000016421", "PMC6708958", "31348242"]}, {"Citation": "Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, et al. Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules. 2021;26(4):1109. doi: 10.3390/molecules26041109.", "ArticleIdList": ["10.3390/molecules26041109", "PMC7922180", "33669817"]}, {"Citation": "Mehta S, Kadian V, Dalal S, Dalal P, Kumar S, Garg M, et al. A fresh look on bergenin: vision of its novel drug delivery systems and pharmacological activities. Future Pharmacol. 2022;2(1):64\u201391. doi: 10.3390/futurepharmacol2010006.", "ArticleIdList": ["10.3390/futurepharmacol2010006"]}, {"Citation": "Tahtamouni, L., Ahram, M., Koblinski, J., Rolfo, C. Molecular Regulation of Cancer Cell Migration, Invasion, and Metastasis, vol. 2019, Analytical Cellular Pathology (Hindawi, 2019).", "ArticleIdList": ["PMC6536998", "31218208"]}, {"Citation": "Xu J, Liu D, Niu H, Zhu G, Xu Y, Ye D, et al. Resveratrol reverses Doxorubicin resistance by inhibiting epithelial\u2013mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J. Exp. Clin. Cancer Res. 2017;36(1):1\u201314. doi: 10.1186/s13046-016-0487-8.", "ArticleIdList": ["10.1186/s13046-016-0487-8", "PMC5270306", "28126034"]}, {"Citation": "Tian Y, Liu R, Hou X, Gao Z, Liu X, Zhang W. SIRT2 promotes the viability, invasion and metastasis of osteosarcoma cells by inhibiting the degradation of Snail. Cell Death Dis. 2022;13(11):1\u201310. doi: 10.1038/s41419-022-05388-2.", "ArticleIdList": ["10.1038/s41419-022-05388-2", "PMC9640536", "36344502"]}, {"Citation": "Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30(16):2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Malhotra L, Sharma S, Hariprasad G, Dhingra R, Mishra V, Sharma RS, et al. Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2022;1869(12):119343. doi: 10.1016/j.bbamcr.2022.119343.", "ArticleIdList": ["10.1016/j.bbamcr.2022.119343", "36007676"]}, {"Citation": "Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u20132504. doi: 10.1101/gr.1239303.", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: A Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091\u20131093. doi: 10.1093/bioinformatics/btp101.", "ArticleIdList": ["10.1093/bioinformatics/btp101", "PMC2666812", "19237447"]}, {"Citation": "S\u00f6rme P, Arnoux P, Kahl-Knutsson B, Leffler H, Rini JM, Nilsson UJ. Structural and thermodynamic studies on cation\u2212\u03c0 interactions in lectin\u2013ligand complexes: High-affinity galectin-3 inhibitors through fine-tuning of an arginine\u2212arene interaction. J. Am. Chem. Soc. 2005;127(6):1737\u20131743. doi: 10.1021/ja043475p.", "ArticleIdList": ["10.1021/ja043475p", "15701008"]}, {"Citation": "Yadav P, Kumar M, Bansal R, Kaur P, Ethayathulla AS. Structure model of ferrochelatase from Salmonella typhi elucidating metalation mechanism. Int. J. Biol. Macromol. 2019;127:585\u2013593. doi: 10.1016/j.ijbiomac.2019.01.066.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.01.066", "30660563"]}, {"Citation": "Naz F, Mashkoor M, Sharma P, Haque MA, Kapil A, Kumar M, et al. Drug repurposing approach to target FtsZ cell division protein from Salmonella typhi. Int. J. Biol. Macromol. 2020;159:1073\u20131083. doi: 10.1016/j.ijbiomac.2020.05.063.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.05.063", "32417543"]}, {"Citation": "Malhotra L, Goyal HK, Jhuria S, Dev K, Kumar S, Kumar M, et al. Curcumin rescue p53Y220C in BxPC-3 pancreatic adenocarcinomas cell line: Evidence-based on computational, biophysical, and in vivo studies. Biochim. Biophys. Acta (BBA) Gen. Subj. 2021;1865(2):129807. doi: 10.1016/j.bbagen.2020.129807.", "ArticleIdList": ["10.1016/j.bbagen.2020.129807", "33278547"]}, {"Citation": "Berendsen HJ, van der Spoel D, van Drunen R. GROMACS: A message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 1995;91(1\u20133):43\u201356. doi: 10.1016/0010-4655(95)00042-E.", "ArticleIdList": ["10.1016/0010-4655(95)00042-E"]}, {"Citation": "Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Schmid N, Eichenberger AP, Choutko A, Riniker S, Winger M, Mark AE, et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 2011;40(7):843\u2013856. doi: 10.1007/s00249-011-0700-9.", "ArticleIdList": ["10.1007/s00249-011-0700-9", "21533652"]}, {"Citation": "Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J. Phys. Chem. A. 2001;105(43):9954\u20139960. doi: 10.1021/jp003020w.", "ArticleIdList": ["10.1021/jp003020w"]}, {"Citation": "Kumari R, Kumar R, Consortium OSDD, Lynn A. g_mmpbsa\u00b7 A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 2014;54(7):1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Sharma S, Malhotra L, Yadav P, Mishra V, Sharma RS, Samath EA. Genistein: A novel inhibitor of IL-6/IL-6R interface of the Interleukin-6-mediated STAT3 dependent pathway of carcinogenesis. J. Mol. Struct. 2022;1258:132668. doi: 10.1016/j.molstruc.2022.132668.", "ArticleIdList": ["10.1016/j.molstruc.2022.132668"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "4"}, {"Year": "2024", "Month": "6", "Day": "13"}, {"Year": "2024", "Month": "7", "Day": "4", "Hour": "0", "Minute": "44"}, {"Year": "2024", "Month": "7", "Day": "4", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "7", "Day": "3", "Hour": "23", "Minute": "27"}, {"Year": "2024", "Month": "7", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["38961106", "PMC11222472", "10.1038/s41598-024-64781-3", "10.1038/s41598-024-64781-3"]}}]}